David Elder

3.1k total citations
40 papers, 1.6k citations indexed

About

David Elder is a scholar working on Spectroscopy, Pharmaceutical Science and Environmental Chemistry. According to data from OpenAlex, David Elder has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Spectroscopy, 7 papers in Pharmaceutical Science and 7 papers in Environmental Chemistry. Recurrent topics in David Elder's work include Analytical Chemistry and Chromatography (10 papers), Drug Solubulity and Delivery Systems (7 papers) and Organic and Inorganic Chemical Reactions (5 papers). David Elder is often cited by papers focused on Analytical Chemistry and Chromatography (10 papers), Drug Solubulity and Delivery Systems (7 papers) and Organic and Inorganic Chemical Reactions (5 papers). David Elder collaborates with scholars based in United Kingdom, Denmark and United States. David Elder's co-authors include René Holm, Heidi Lopez de Diego, David J. Snodin, Martin Kuentz, Andrew Teasdale, Kevin D. Altria, Kevin L. Facchine, Luigi G. Martini, Matthew Roberts and James L. Ford and has published in prestigious journals such as Journal of Chromatography A, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

David Elder

37 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Elder 447 415 394 267 245 40 1.6k
Kenneth C. Waterman 309 0.7× 233 0.6× 460 1.2× 335 1.3× 320 1.3× 41 1.5k
Anuradha Gajjar 435 1.0× 261 0.6× 596 1.5× 396 1.5× 327 1.3× 47 1.9k
Krishnaswamy Raghavan 594 1.3× 312 0.8× 447 1.1× 222 0.8× 160 0.7× 26 1.4k
Salomon Stavchansky 245 0.5× 272 0.7× 651 1.7× 511 1.9× 143 0.6× 58 2.1k
Ketan T. Savjani 445 1.0× 227 0.5× 588 1.5× 316 1.2× 270 1.1× 11 1.6k
Jignasa Savjani 461 1.0× 233 0.6× 601 1.5× 366 1.4× 340 1.4× 28 1.8k
Dorothy J Saville 660 1.5× 322 0.8× 598 1.5× 207 0.8× 115 0.5× 30 1.5k
John Comer 537 1.2× 819 2.0× 461 1.2× 535 2.0× 593 2.4× 32 2.4k
Ajaz Hussain 400 0.9× 371 0.9× 1.2k 3.0× 394 1.5× 282 1.2× 63 2.7k
Christoph Saal 424 0.9× 259 0.6× 432 1.1× 200 0.7× 139 0.6× 24 1.0k

Countries citing papers authored by David Elder

Since Specialization
Citations

This map shows the geographic impact of David Elder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Elder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Elder more than expected).

Fields of papers citing papers by David Elder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Elder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Elder. The network helps show where David Elder may publish in the future.

Co-authorship network of co-authors of David Elder

This figure shows the co-authorship network connecting the top 25 collaborators of David Elder. A scholar is included among the top collaborators of David Elder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Elder. David Elder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stangeby, P.C., X. Bonnin, J.M. Canik, et al.. (2021). The role of the target electron temperature as a key detachment parameter. Bulletin of the American Physical Society. 1 indexed citations
2.
Elder, David, George E. Johnson, & David J. Snodin. (2021). Tolerability of risk: A commentary on the nitrosamine contamination issue. Journal of Pharmaceutical Sciences. 110(6). 2311–2328. 25 indexed citations
3.
Snodin, David J. & David Elder. (2019). Short commentary on NDMA (N-nitrosodimethylamine) contamination of valsartan products. Regulatory Toxicology and Pharmacology. 103. 325–329. 62 indexed citations
4.
Elder, David, Gregory K. Webster, Yun Mao, et al.. (2017). Industry's View on Using Quality Control, Biorelevant, and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration, and Commercialization. Journal of Pharmaceutical Sciences. 107(1). 34–41. 66 indexed citations
5.
Elder, David. (2016). 'A perfect storm' - the 2016 double dissolution election.
6.
Elder, David, René Holm, & Martin Kuentz. (2016). Medicines for Pediatric Patients—Biopharmaceutical, Developmental, and Regulatory Considerations. Journal of Pharmaceutical Sciences. 106(4). 950–960. 16 indexed citations
7.
Elder, David, Martin Kuentz, & René Holm. (2016). Antibiotic Resistance: The Need For a Global Strategy. Journal of Pharmaceutical Sciences. 105(8). 2278–2287. 21 indexed citations
8.
Knopp, Matthias Manne, Korbinian Löbmann, David Elder, Thomas Rades, & René Holm. (2015). Recent advances and potential applications of modulated differential scanning calorimetry (mDSC) in drug development. European Journal of Pharmaceutical Sciences. 87. 164–173. 55 indexed citations
9.
Borman, Phil J., et al.. (2015). Universal detection in high performance liquid chromatography. 20(3). 47–51. 2 indexed citations
10.
Holm, René & David Elder. (2015). Analytical advances in pharmaceutical impurity profiling. European Journal of Pharmaceutical Sciences. 87. 118–135. 56 indexed citations
11.
Elder, David, et al.. (2015). Meeting commentary–“Parkinson’s disease: From patient to product”. International Journal of Pharmaceutics. 494(1). 167–171. 2 indexed citations
12.
Elder, David, Martin Kuentz, & René Holm. (2015). Pharmaceutical excipients — quality, regulatory and biopharmaceutical considerations. European Journal of Pharmaceutical Sciences. 87. 88–99. 113 indexed citations
13.
Elder, David. (2014). The role of the speaker in minority government - the case of the Australian House of Representatives 2010-2013. 29(1). 6.
14.
Elder, David & René Holm. (2012). Aqueous solubility: Simple predictive methods (in silico, in vitro and bio-relevant approaches). International Journal of Pharmaceutics. 453(1). 3–11. 48 indexed citations
15.
Elder, David, René Holm, & Heidi Lopez de Diego. (2012). Use of pharmaceutical salts and cocrystals to address the issue of poor solubility. International Journal of Pharmaceutics. 453(1). 88–100. 318 indexed citations
16.
Elder, David, Andrew Teasdale, Van D. Reif, et al.. (2010). The Utility of Sulfonate Salts in Drug Development. Journal of Pharmaceutical Sciences. 99(7). 2948–2961. 85 indexed citations
17.
Zomer, Simeone, et al.. (2008). Detection and assessment of co‐association in inhalable drug particles using aerosol time‐of‐flight mass spectrometry. Rapid Communications in Mass Spectrometry. 22(23). 3873–3882. 6 indexed citations
18.
Teasdale, Andrew, Andrew M. Lipczynski, Van D. Reif, et al.. (2008). Development and validation of an automated static headspace gas chromatography–mass spectrometry (SHS-GC–MS) method for monitoring the formation of ethyl methane sulfonate from ethanol and methane sulfonic acid. Journal of Pharmaceutical and Biomedical Analysis. 48(5). 1339–1344. 20 indexed citations
19.
Elder, David, et al.. (2007). Managing Horizontal Accountability. Journal for Quality and Participation. 30. 1 indexed citations
20.
Altria, Kevin D. & David Elder. (2003). Overview of the status and applications of capillary electrophoresis to the analysis of small molecules. Journal of Chromatography A. 1023(1). 1–14. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026